KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 18 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,888,000 | -58.5% | 2,517,000 | -44.3% | 0.00% | -50.0% |
| Q2 2021 | $4,550,000 | +761.7% | 4,517,000 | +773.7% | 0.00% | – |
| Q1 2021 | $528,000 | -91.5% | 517,000 | -89.7% | 0.00% | -100.0% |
| Q4 2020 | $6,243,000 | +5.4% | 5,017,000 | +0.5% | 0.00% | -25.0% |
| Q3 2020 | $5,921,000 | – | 4,994,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 15,000,000 | $15,028,000 | 1.61% |
| Context Capital Management, LLC | 13,000 | $13,039,000 | 1.21% |
| STEELHEAD PARTNERS LLC | 14,000,000 | $13,941,000 | 0.92% |
| PenderFund Capital Management Ltd. | 3,000,000 | $3,754,000 | 0.88% |
| AQR Arbitrage LLC | 7,000,000 | $7,021,000 | 0.20% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 20,000,000 | $19,960,000 | 0.16% |
| CSS LLC/IL | 2,000,000 | $1,991,000 | 0.08% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,000,000 | $10,456,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 17,500,000 | $17,552,000 | 0.02% |
| Daiwa Securities Group Inc. | 3,000,000 | $3,004,000 | 0.02% |